The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research.
Andrade
Chittaranjan
C
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology*; D006801:Humans; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D011788:Quality of Life; D015363:Quinolones / Q000627:therapeutic use; D012307:Risk Factors; D016728:Self-Injurious Behavior / Q000209:etiology* / Q000517:prevention & control*; D013844:Thiazoles / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D013844:Thiazoles; D001569:Benzodiazepines; C092292:ziprasidone; D000068180:Aripiprazole; D000077152:Olanzapine